Assessment of population-based HIV RNA levels in a rural east african setting using a fingerprick-based blood collection method

Clinical Infectious Diseases

Volumn 56, Issue 4, 2013, Pages 598-605

  Jain, Vivek ^a,b   Liegler, Teri ^a   Kabami, Jane ^b,c   Chamie, Gabriel ^a,b   Clark, Tamara D ^a,b   Black, Douglas ^a,b   Geng, Elvin H ^a,b   Kwarisiima, Dalsone ^b,c   Wong, Joseph K ^d   Abdel Mohsen, Mohamed ^a   Sonawane, Nitin ^e   Aweeka, Francesca T ^e   Thirumurthy, Harsha ^b,f   Petersen, Maya L ^b,g   Charlebois, Edwin D ^b,e   Kamya, Moses R ^b   Havlir, Diane V ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAKERERE UNIVERSITY   (Uganda)

^c Mulago Mbarara Teaching Hospitals' Joint AIDS Program (MJAP)   (Uganda)

^d Department of Medicine ^*  (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f IL   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ART effectiveness; epidemiology; fingerprick; population HIV RNA levels; viral load

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; NEVIRAPINE; VIRUS RNA;

ADULT; AFRICA; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CHILD; FEMALE; FINGERPRICK BASED BLOOD COLLECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PHLEBOTOMY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; VEIN PUNCTURE; VIRUS LOAD;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MALE; PHLEBOTOMY; PREDICTIVE VALUE OF TESTS; RNA, VIRAL; RURAL POPULATION; UGANDA; VIRAL LOAD; YOUNG ADULT;

EID: 84873035130     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis881     Document Type: Article

References (25)

1. Joint United Nations Programme on HIV/AIDS. UNAIDS World AIDS Day Report: 2011:1-52. Available at: http://www.unaids.org/en/media/unaids/contentassets/ documents/unaidspublication/2011/JC2216-WorldAIDSday-report-2011-en.pdf. Accessed 9 June 2012.
2. Burns DN, Dieffenbach CW, Vermund SH. Rethinking prevention of HIV type 1 infection. Clin Infect Dis 2010; 51:725-31.
3. Millett GA, Crowley JS, Koh H, et al. A way forward: the national HIV/AIDS strategy and reducing HIV incidence in the United States. J Acquir Immune Defic Syndr 2010; 55:S144-7.
4. Castel AD, Befus M, Willis S, et al. Use of the community viral load as a population-based biomarker of HIV burden. AIDS 2012; 26: 345-53.
5. Das M, Chu PL, Santos GM, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One 2010; 5:e11068.
6. Montaner JS, Lima VD, Barrios R, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 2010; 376:532-9.
7. Wood E, Kerr T, Marshall BD, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ 2009; 338:b1649.
8. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921-9.
9. Hughes JP, Baeten JM, Lingappa JR, et al. Determinants of per-coitalact HIV-1 infectivity among African HIV-1-serodiscordant couples. J Infect Dis 2012; 205:358-65.
10. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365: 493-505.
11. Cornell M, Technau K, Fairall L, et al. Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration. S Afr Med J 2009; 99:653-60.
12. Filler SJ, Berruti AA, Menzies N, et al. Characteristics of HIV care and treatment in PEPFAR-supported sites. J Acquir Immune Defic Syndr 2011; 57:e1-6.
13. Chamie G, Kwarisiima D, Clark TD, et al. Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural Uganda. PLoS One 2012; 7:e43400.
14. Ministry of Health Uganda. Uganda national policy guidelines for HIV voluntary counseling and testing, Kampala, Uganda: Director General Health Services, 2005.
15. Mtapuri-Zinyowera S, Chideme M, Mangwanya D, et al. Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe. J Acquir Immune Defic Syndr 2010; 55:1-7.
16. Diaw PA, Daneau G, Coly AA, et al. Multisite evaluation of a pointof-care instrument for CD4(+) T-cell enumeration using venous and finger-prick blood: the PIMA CD4. J Acquir Immune Defic Syndr 2011; 58:e103-11.
17. Ministry of Health Uganda. National antiretroviral treatment guidelines for adults and children. Kampala, Uganda: Director General Health Services, 1st ed. 2003:1-66.
18. Ministry of Health Uganda. National antiretroviral treatment guidelines for adults, adolescents, and children. Kampala, Uganda: Director General Health Services, 3rd ed. 2009:1-80.
19. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach-2010 revision. Geneva, Switzerland: WHO, 2010:1-156.
20. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Washington, DC: Department of Health and Human Services, 2011:1-167.
21. Thompson MA, Aberg JA, Cahn P, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA 2010; 304:321-33.
22. Centers for Disease Control and Prevention. Vital signs: HIV prevention through care and treatment-United States. MMWR Morbid Mortal Wkly Rep 2011; 60:1618-23.
23. Young SD, Hlavka Z, Modiba P, et al. HIV-related stigma, social norms, and HIV testing in Soweto and Vulindlela, South Africa: National Institutes of Mental Health Project Accept (HPTN 043). J Acquir Immune Defic Syndr 2010; 55:620-4.
24. Morrill AC, Noland C. Interpersonal issues surrounding HIV counseling and testing, and the phenomenon of "testing by proxy." J Health Commun 2006; 11:183-98.
25. Mills EJ, Beyrer C, Birungi J, Dybul MR. Engaging men in prevention and care for HIV/AIDS in Africa. PLoS Med 2012; 9:e1001167.